Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N1 VLP Vaccine Phase I/IIa in Healthy Adults
NCT00519389Phase 2Completed
- Sponsor
- Novavax
- Start
- Jul 2007
- Primary completion
- Nov 2008
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of H5 VLP vaccine + alhydrogel in Influenza A H5N1 infection (H5N1), sponsored by Novavax. Started Jul 2007; status: completed.
02
Drugs
H5 VLP vaccine + alhydrogel
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT00519389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519389.